GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Sunder Biomedical Tech Co 4115.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

6.97

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Sunder Biomedical Tech Co

Its shares trade on Taipei Exchange under the ticker 4115.TWO. It has been listed since 31 August 2022. In the fiscal year to 31 December 2025, it reported revenue of TWD 753.5m and a net loss of TWD 16.3m. At that date it held total assets of TWD 1.27bn and shareholders' equity of TWD 757.9m.

Sunder Biomedical Tech.Co., Ltd. engages in the manufacture and sales of medical products. The company is headquartered in Baojhong, Yunlin. The company went IPO on 2022-08-31. The main products are medical consumables such as blood circuit catheters, puncture needles, infusion sets, suction tubing, dosing sets, waste fluid collection bags, protective covers, medical components; laparoscopic smoke filters, suction sets, pick-up bags, medical polyvinyl chloride (PVC) pellets, NON-diethylhexyl phthalate(DEHP) PVC, and other medical grade materials. The firm also provides sterilization and laboratory services, masks, tubes, and nucleic acid extraction well tray consumables foundry services.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
31 Aug 2022

Leadership

Pay as last reported

  • Mr. Yuanqi YuGeneral Manager, since 2011
  • Mingjia XieIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Sunder Biomedical Tech Co Ltd manufactures blood circuit catheters and infusion sets in Baojhong, Yunlin.
  • The company produces medical consumables including puncture needles and waste fluid collection bags.
  • Sunder Biomedical Tech Co Ltd offers sterilization and laboratory services for medical products.

Weaknesses

  • The company's main products are medical consumables like blood circuit catheters and infusion sets.
  • Sunder Biomedical Tech Co Ltd focuses on medical consumables without expanding into new segments.
  • The company's business is limited to medical consumables and sterilization services.

Opportunities

  • Sunder Biomedical Tech Co Ltd can expand into laparoscopic smoke filters and suction sets market.
  • The company can leverage its production of NON-diethylhexyl phthalate(DEHP) PVC materials.
  • Sunder Biomedical Tech Co Ltd can grow by providing nucleic acid extraction well tray consumables.

Threats

  • The company faces competition from other medical consumables manufacturers in TW.
  • Sunder Biomedical Tech Co Ltd must comply with medical product regulations in TW.
  • The company's reliance on medical consumables may limit growth opportunities.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.